Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong · Delayed Price · Currency is HKD 3.220
+0.055 (1.74%)
Aug 21, 2026, 3:29 PM HKT
HKG:8247 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 170.63 | 184.29 | 263.07 | 289.07 | 373.07 | 348.23 | |
Revenue Growth | -24.19% | -29.95% | -9.00% | -22.52% | 7.13% | 7.06% |
Cost of Revenue | 104.86 | 113.37 | 154.67 | 161.71 | 226.79 | 204.63 |
Gross Profit | 65.76 | 70.92 | 108.4 | 127.37 | 146.28 | 143.59 |
Selling, General & Admin | 86.17 | 93.27 | 106.6 | 110.4 | 99.67 | 93.27 |
Research & Development | 23.4 | 26.82 | 33.42 | 35.81 | 26.87 | 24.94 |
Operating Expenses | 114.19 | 124.76 | 145.69 | 146.78 | 126.54 | 118.22 |
Operating Income | -48.42 | -53.84 | -37.29 | -19.41 | 19.74 | 25.38 |
Interest Expense | -6.84 | -6.81 | -9.3 | -6.4 | -6.82 | -10.57 |
Interest & Investment Income | 1.56 | 1.56 | 1.66 | 0.33 | 0.34 | 0.22 |
Earnings From Equity Investments | 4.5 | 0.1 | -0.42 | 12.35 | 6.53 | 1.57 |
Other Non Operating Income (Expenses) | -4.35 | -3.75 | -1.41 | -3.88 | -1.08 | -10.07 |
EBT Excluding Unusual Items | -53.56 | -62.75 | -46.75 | -17.02 | 18.71 | 6.54 |
Gain (Loss) on Sale of Assets | 0.05 | - | - | - | - | - |
Asset Writedown | -4.47 | -4.5 | -12.97 | -0.59 | -0.19 | -0.13 |
Pretax Income | -57.97 | -67.25 | -59.72 | -17.61 | 18.52 | 6.41 |
Income Tax Expense | -2.49 | -2.23 | -2.83 | 1.63 | 4.31 | 3.25 |
Earnings From Continuing Operations | -55.48 | -65.02 | -56.89 | -19.24 | 14.2 | 3.16 |
Minority Interest in Earnings | 13.98 | 13.88 | 14.36 | 7.59 | -6.1 | -4.3 |
Net Income | -41.5 | -51.14 | -42.53 | -11.65 | 8.11 | -1.14 |
Net Income to Common | -41.5 | -51.14 | -42.53 | -11.65 | 8.11 | -1.14 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 139 | 145 | 145 | 145 | 145 | 145 |
Shares Outstanding (Diluted) | 139 | 145 | 145 | 145 | 145 | 145 |
Shares Change | -3.78% | - | - | - | - | - |
EPS (Basic) | -0.30 | -0.35 | -0.29 | -0.08 | 0.06 | -0.01 |
EPS (Diluted) | -0.30 | -0.35 | -0.29 | -0.08 | 0.06 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -9.93 | -32.39 | 11.36 | -22.91 | 28.19 | 45.15 |
Free Cash Flow Per Share | -0.07 | -0.22 | 0.08 | -0.16 | 0.20 | 0.31 |
Gross Margin | 38.54% | 38.48% | 41.21% | 44.06% | 39.21% | 41.23% |
Operating Margin | -28.38% | -29.22% | -14.17% | -6.72% | 5.29% | 7.29% |
Profit Margin | -24.32% | -27.75% | -16.17% | -4.03% | 2.17% | -0.33% |
Free Cash Flow Margin | -5.82% | -17.57% | 4.32% | -7.92% | 7.56% | 12.97% |
EBITDA | -33.68 | -38.14 | -22.7 | -2.35 | 40.92 | 49.93 |
EBITDA Margin | -19.74% | -20.69% | -8.63% | -0.81% | 10.97% | 14.34% |
D&A For EBITDA | 14.74 | 15.7 | 14.59 | 17.06 | 21.18 | 24.55 |
EBIT | -48.42 | -53.84 | -37.29 | -19.41 | 19.74 | 25.38 |
EBIT Margin | -28.38% | -29.22% | -14.17% | -6.72% | 5.29% | 7.29% |
Effective Tax Rate | - | - | - | - | 23.30% | 50.68% |